Clinical Trial Update: Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating alcohol septal ablation for obstructive hypertrophic cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: COMPLETED